Executive Management Team

Roger Hinton, Managing Director

Dr Roger Hinton has over 30 years’ experience within the pharmaceutical industry both at the operational and management level and has worked in research, product and process development and business development. Dr Hinton has a B. Sc. (Hons) in Microbiology and Ph.D. in microbial enzymology. He was formerly the PHE Head of Development and Production and is now the Managing Director of Porton Biopharma Limited.

Howard Tranter, Commercial Director

Dr Howard Tranter, has over 30 years’ experience working in the development and manufacture of biologics from commercially useful microbial pathogens. He was involved in the development of Dysport®, a therapeutic form of botulinum type A toxin and its successful licensure to Ipsen Ltd. Prior to joining Porton Biopharma he held a Senior Business Development Manager position with Public Health England with particular responsibilities for Development and Production activities and was responsible for initiating and maintaining public-private collaborations with commercial vaccine developers and manufacturers and the licensing of PHE technology to such partners.

Shane Jones, Director of Production

Shane has a B. Sc. (Hons) degree in Biochemistry and over 20 years’ experience in the biopharmaceutical industry. He has held management positions in both Quality Control and Manufacturing divisions and has significant experience of regulatory inspections. Shane joined HPA/PHE as Deputy Head of Manufacturing in 2009 becoming Head of Manufacturing in 2012. Prior to this, Shane spent 17 years at Therapeutic Antibodies UK Limited/Protherics UK Limited, comprising 9 years as Quality Control Manager and 7 years as Production Manager/Head of Manufacturing. In his role as Head of Manufacturing at Protherics, Shane also headed Technical Support and Process Development functions.

Nara Ringrose, Director of Human Resources

Dr Nara Ringrose brings more than 25 years of experience in strategic and operational HR. She is a Chartered Fellow CIPD; Chartered Fellow CMI; Certified HR Practitioner, Certified HR Executive and has a PhD in geopolitics; BA(Hons) in economic, political and human geography. Prior to joining Porton Biopharma, Nara held a number of senior HR posts in the engineering; oil and gas; mining & exploration; education and manufacturing sectors where she was responsible for HR strategies and advised on best people practices and how organisations add value to clients and investors through strategic and operational HR practices.

Paul Gomm, Director of Quality

Paul  has taken over from Dr Peter Hughes as Director of Quality as of 3rd April 2018 and his profile will be available soon.

Julie Miller, Director of Development

Dr Julie Miller has over 30 years` experience in the research and development of pharmaceutical products. She has a BSC (Hons) in Applied Biology and a PhD in Protein Biochemistry. Prior to joining Porton Biopharma, Julie held management positions at the Defence Science & Technology Laboratory and was Scientific Advisor to the MOD and the UK technical lead on the international Medical Countermeasures Consortium; developing vaccines and therapeutics for military personnel. She has considerable experience in developing products under the FDA Animal Rule and evaluating the clinical safety of such products. In addition, she has regulatory experience, working as a pharmaceutical assessor at the MHRA.

Alan Jennings, Director of Regulatory Affairs

After obtaining a B. Sc. degree in Microbiology and a Ph. D. in Molecular Biology, Alan worked in the US for a period before returning to the UK. He has considerable experience in the pharmaceutical industry, having held senior positions in project management, Quality Assurance and Quality Control. He has experience in Regulatory Affairs relating to the EU, US and Japan.

Roger Price, Director of Logistics & Project Management

Roger Price has over 30 years’ experience in the life science industry including the last 10 years within a pharmaceutical manufacturing based organisation. A graduate chemist he has previously held positions in QC, manufacturing, development and research with GE Life Sciences.

 

Nigel Mackie, Company Secretary

After obtaining a degree in Economics & Statistics, Nigel qualified as an accountant. He has extensive experience working in a variety of senior finance roles in the private sector, in both the service and manufacturing industries; this includes periods with LRV Industries, Warner Lambert (Pfizer) and Coopervision, both in the UK and overseas.

 

Penny Turner, Director of Finance

Penny obtained a BSc in Molecular  Biology and Biochemistry before qualifying as a Chartered Accountant with Deloitte.  She brings more than 20 years of experience in senior finance positions, and has led a range of organisations through finance system implementations, change programmes and commercial challenges.  Previous roles have included pharmaceutical and biotech companies in the public and private sectors.   She is also a qualified project manager.

Mike Raine, Director of Engineering

Mike has 20 years’ experience in Commissioning and Qualification, technical roles and project management with major Pharmaceutical and Service provider companies, where he has established a track record in the delivery of Engineering projects, Quality Systems & Assurance, and Process & Equipment Validation